Blogs : #AMD

Sort
Dry eyes
Dry eyes Tears play a crucial role in keeping our eyes moist, ensuring clear vision by letting light effectively pass through the eye's lens, and supplying oxygen to nourish the eye. They also help fend off infections and keep foreign substances at bay.   Now, when it comes to dry eyes, it's a pretty common issue that can stem from abnormal tear production or tears evaporating too quickly. This can lead to discomfort, irritation, that feeling like there's something foreign in your eye, redness, pain, blurry vision that gets better with blinking, or even feeling like your eyes are tired and heavy. What causes dry eyes can vary—getting older, being a woman (yeah, we're more prone to it), certain allergy medications, spending loads of time on screens, being in places with dust and smoke, gusty winds, and bright lights, they can all have a hand in it.   But hey, the good news is there are ways to tackle dry eyes:   Keep away from things that can make it worse, like strong winds and dust, by popping on some sunglasses and protecting those peepers. Remember to take breaks or blink more often, especially when you're glued to screens for a while. You've got these cool eye drops called artificial tears. There's a type for daytime (more watery) and nighttime (a bit thicker). Which one to use depends on how serious your dry eye situation is. Sometimes your doc might suggest special eye drops that encourage your eyes to make more tears. Give your eyes a treat with warm, clean cloths over your closed eyelids to help them feel better. If the dry eye struggle is real and isn't improving, it's wise to chat with an eye doctor.   All in all, dry eyes can be a bother, but there are solutions out there. It's important to take good care of your eyes, especially when it's all dry outside. If you suspect you've got dry eyes, having a chat with an eye care expert is a smart move.      
Read More
Retina Center
āļˆāļ­āļ›āļĢāļ°āļŠāļēāļ—āļ•āļēāđ€āļŠāļ·āđˆāļ­āļĄāđāļĨāļ°āđ€āļ—āļ„āđ‚āļ™āđ‚āļĨāļĒāļĩāļāļēāļĢāļĢāļąāļāļĐāļēāđƒāļ™āļ›āļąāļˆāļˆāļļāļšāļąāļ™
āļˆāļ­āļ›āļĢāļ°āļŠāļēāļ—āļ•āļēāđ€āļŠāļ·āđˆāļ­āļĄāđāļĨāļ°āđ€āļ—āļ„āđ‚āļ™āđ‚āļĨāļĒāļĩāļāļēāļĢāļĢāļąāļāļĐāļēāđƒāļ™āļ›āļąāļˆāļˆāļļāļšāļąāļ™ āļˆāļ­āļ›āļĢāļ°āļŠāļēāļ—āļ•āļēāđ€āļŠāļ·āđˆāļ­āļĄ (Age-related Macular Degeneration āļŦāļĢāļ·āļ­ AMD) āđ€āļ›āđ‡āļ™āđ‚āļĢāļ„āļ—āļĩāđˆāđ€āļāļīāļ”āļˆāļēāļāļ„āļ§āļēāļĄāđ€āļŠāļ·āđˆāļ­āļĄāļ‚āļ­āļ‡āđ€āļ‹āļĨāļĨāđŒāļšāļĢāļīāđ€āļ§āļ“āļˆāļļāļ”āļĻāļđāļ™āļĒāđŒāļāļĨāļēāļ‡āļ‚āļ­āļ‡āļˆāļ­āļ›āļĢāļ°āļŠāļēāļ—āļ•āļē (Macula) āļ‹āļķāđˆāļ‡āđ€āļ›āđ‡āļ™āļŠāđˆāļ§āļ™āļ—āļĩāđˆāļŠāļģāļ„āļąāļāļ—āļĩāđˆāļŠāļļāļ”āđƒāļ™āļāļēāļĢāļĄāļ­āļ‡āđ€āļŦāđ‡āļ™ āļ—āļģāđƒāļŦāđ‰āļŠāļđāļāđ€āļŠāļĩāļĒāļāļēāļĢāļĄāļ­āļ‡āđ€āļŦāđ‡āļ™āļŠāđˆāļ§āļ™āļāļĨāļēāļ‡āđ„āļ›āļ—āļĩāļĨāļ°āļ™āđ‰āļ­āļĒ āļ­āļēāļˆāđ€āļĢāļīāđˆāļĄāļˆāļēāļāļĄāļ­āļ‡āđ€āļŦāđ‡āļ™āļ āļēāļžāļ•āļĢāļ‡āļāļĨāļēāļ‡āđ„āļĄāđˆāļŠāļąāļ” āļ āļēāļžāļšāļīāļ”āđ€āļšāļĩāđ‰āļĒāļ§ āļŠāļĩāļœāļīāļ”āđ€āļžāļĩāđ‰āļĒāļ™ āļˆāļ™āļāļĢāļ°āļ—āļąāđˆāļ‡āļĄāļ­āļ‡āđ„āļĄāđˆāđ€āļŦāđ‡āļ™āļ āļēāļžāļ•āļĢāļ‡āļāļĨāļēāļ‡āđƒāļ™āļ—āļĩāđˆāļŠāļļāļ” āđ‚āļ”āļĒāļ—āļąāđˆāļ§āđ„āļ› āļˆāļ­āļ›āļĢāļ°āļŠāļēāļ—āļ•āļēāđ€āļŠāļ·āđˆāļ­āļĄ āļĄāļąāļāļžāļšāđƒāļ™āļœāļđāđ‰āļ—āļĩāđˆāļĄāļĩāļ­āļēāļĒāļļ 50 āļ›āļĩāļ‚āļķāđ‰āļ™āđ„āļ› āđāļĨāļ°āļ„āļ§āļēāļĄāđ€āļŠāļĩāđˆāļĒāļ‡āļˆāļ°āđ€āļžāļīāđˆāļĄāļ‚āļķāđ‰āļ™āļ•āļēāļĄāļ­āļēāļĒāļļāļ—āļĩāđˆāļĄāļēāļāļ‚āļķāđ‰āļ™ āļ™āļ­āļāļˆāļēāļāļ™āļĩāđ‰ āļ›āļąāļˆāļˆāļąāļĒāđ€āļŠāļĩāđˆāļĒāļ‡āļ­āļ·āđˆāļ™ āđ† āļ—āļĩāđˆāļ­āļēāļˆāļ—āļģāđƒāļŦāđ‰āđ€āļāļīāļ”āđ‚āļĢāļ„āļ™āļĩāđ‰āđ„āļ”āđ‰ āđ€āļŠāđˆāļ™ āļāļēāļĢāļŠāļđāļšāļšāļļāļŦāļĢāļĩāđˆ āđ‚āļĢāļ„āļ„āļ§āļēāļĄāļ”āļąāļ™āđ‚āļĨāļŦāļīāļ•āļŠāļđāļ‡ āđ‚āļĢāļ„āļ­āđ‰āļ§āļ™ āđāļĨāļ°āļžāļąāļ™āļ˜āļļāļāļĢāļĢāļĄ āļˆāļ­āļ›āļĢāļ°āļŠāļēāļ—āļ•āļēāđ€āļŠāļ·āđˆāļ­āļĄ āđāļšāđˆāļ‡āļ­āļ­āļāđ€āļ›āđ‡āļ™ 2 āļŠāļ™āļīāļ” āđ„āļ”āđ‰āđāļāđˆ āļˆāļ­āļ›āļĢāļ°āļŠāļēāļ—āļ•āļēāđ€āļŠāļ·āđˆāļ­āļĄāđāļšāļšāđāļŦāđ‰āļ‡ (Dry AMD): āđ€āļ›āđ‡āļ™āļŠāļ™āļīāļ”āļ—āļĩāđˆāļžāļšāđ„āļ”āđ‰āļšāđˆāļ­āļĒāļ—āļĩāđˆāļŠāļļāļ” (āļ›āļĢāļ°āļĄāļēāļ“ 80-90%) āđ€āļāļīāļ”āļˆāļēāļāļāļēāļĢāļŠāļ°āļŠāļĄāļ‚āļ­āļ‡āļ‚āļ­āļ‡āđ€āļŠāļĩāļĒāļ—āļĩāđˆāļˆāļ­āļ›āļĢāļ°āļŠāļēāļ—āļ•āļē āļ—āļģāđƒāļŦāđ‰āđ€āļ‹āļĨāļĨāđŒāļĢāļąāļšāđāļŠāļ‡āđ€āļŠāļ·āđˆāļ­āļĄāļŠāļ āļēāļžāļĨāļ‡āđ€āļĢāļ·āđˆāļ­āļĒ āđ† āļ—āļģāđƒāļŦāđ‰āļāļēāļĢāļĄāļ­āļ‡āđ€āļŦāđ‡āļ™āļĨāļ”āļĨāļ‡āļ­āļĒāđˆāļēāļ‡āļŠāđ‰āļē āđ† āļˆāļ­āļ›āļĢāļ°āļŠāļēāļ—āļ•āļēāđ€āļŠāļ·āđˆāļ­āļĄāđāļšāļšāđ€āļ›āļĩāļĒāļ (Wet AMD): āđ€āļ›āđ‡āļ™āļŠāļ™āļīāļ”āļ—āļĩāđˆāļžāļšāđ„āļ”āđ‰āļ™āđ‰āļ­āļĒāļāļ§āđˆāļē (āļ›āļĢāļ°āļĄāļēāļ“ 10-20%) āđāļ•āđˆāļĄāļĩāļ„āļ§āļēāļĄāļĢāļļāļ™āđāļĢāļ‡āļĄāļēāļāļāļ§āđˆāļē āđ€āļāļīāļ”āļˆāļēāļāļāļēāļĢāļŠāļĢāđ‰āļēāļ‡āđ€āļŠāđ‰āļ™āđ€āļĨāļ·āļ­āļ”āđƒāļŦāļĄāđˆāļ—āļĩāđˆāļœāļīāļ”āļ›āļāļ•āļīāđƒāļ•āđ‰āļˆāļ­āļ›āļĢāļ°āļŠāļēāļ—āļ•āļē āđ€āļŠāđ‰āļ™āđ€āļĨāļ·āļ­āļ”āđ€āļŦāļĨāđˆāļēāļ™āļĩāđ‰āļ­āļēāļˆāļĢāļąāđˆāļ§āļŦāļĢāļ·āļ­āđāļ•āļ āļ—āļģāđƒāļŦāđ‰āđ€āļāļīāļ”āļāļēāļĢāļšāļ§āļĄāđāļĨāļ°āđ€āļ›āđ‡āļ™āđāļœāļĨāđ€āļ›āđ‡āļ™āļ—āļĩāđˆāļˆāļ­āļ›āļĢāļ°āļŠāļēāļ—āļ•āļēāļŠāđˆāļ‡āļœāļĨāđƒāļŦāđ‰āļŠāļđāļāđ€āļŠāļĩāļĒāļāļēāļĢāļĄāļ­āļ‡āđ€āļŦāđ‡āļ™āļ­āļĒāđˆāļēāļ‡āļĢāļ§āļ”āđ€āļĢāđ‡āļ§ āļˆāļ­āļ›āļĢāļ°āļŠāļēāļ—āļ•āļēāđ€āļŠāļ·āđˆāļ­āļĄ āđ€āļ›āđ‡āļ™āļŠāļēāđ€āļŦāļ•āļļāļ­āļąāļ™āļ”āļąāļšāļ—āļĩāđˆāļŠāļēāļĄāļ‚āļ­āļ‡āļāļēāļĢāļŠāļđāļāđ€āļŠāļĩāļĒāļāļēāļĢāļĄāļ­āļ‡āđ€āļŦāđ‡āļ™āđƒāļ™āļœāļđāđ‰āļŠāļđāļ‡āļ­āļēāļĒāļļ āđāļĄāđ‰āļ›āļąāļˆāļˆāļļāļšāļąāļ™āļĒāļąāļ‡āđ„āļĄāđˆāļĄāļĩāļ§āļīāļ˜āļĩāļĢāļąāļāļĐāļēāđƒāļŦāđ‰āļŦāļēāļĒāļ‚āļēāļ” āđāļ•āđˆāļĄāļĩāļ—āļēāļ‡āđ€āļĨāļ·āļ­āļāđƒāļ™āļāļēāļĢāļĢāļąāļāļĐāļēāđāļĨāļ°āđ€āļ—āļ„āđ‚āļ™āđ‚āļĨāļĒāļĩāđƒāļŦāļĄāđˆ āđ†āļ—āļĩāđˆāļŠāļēāļĄāļēāļĢāļ–āļŠāļ°āļĨāļ­āļ„āļ§āļēāļĄāđ€āļŠāļ·āđˆāļ­āļĄāđāļĨāļ°āļĢāļąāļāļĐāļēāļ„āļļāļ“āļ āļēāļžāļŠāļĩāļ§āļīāļ•āļ‚āļ­āļ‡āļœāļđāđ‰āļ›āđˆāļ§āļĒāđ„āļ”āđ‰ āļ­āļēāļāļēāļĢāļ‚āļ­āļ‡ āļˆāļ­āļ›āļĢāļ°āļŠāļēāļ—āļ•āļēāđ€āļŠāļ·āđˆāļ­āļĄ āļĄāļĩāļ­āļ°āđ„āļĢāļšāđ‰āļēāļ‡? āļ­āļēāļāļēāļĢāļ‚āļ­āļ‡ āļˆāļ­āļ›āļĢāļ°āļŠāļēāļ—āļ•āļēāđ€āļŠāļ·āđˆāļ­āļĄ āļ‚āļķāđ‰āļ™āļ­āļĒāļđāđˆāļāļąāļšāļĢāļ°āļĒāļ°āļ‚āļ­āļ‡āđ‚āļĢāļ„āļˆāļ­āļ›āļĢāļ°āļŠāļēāļ—āļ•āļēāđ€āļŠāļ·āđˆāļ­āļĄ āđāļšāļšāđāļŦāđ‰āļ‡āļˆāļ°āđāļšāđˆāļ‡āļ•āļēāļĄāļāļĨāļļāđˆāļĄāļ­āļēāļāļēāļĢāđ€āļ›āđ‡āļ™ 3 āļĢāļ°āļĒāļ°: āļĢāļ°āļĒāļ°āđāļĢāļ āļĢāļ°āļĒāļ°āļāļĨāļēāļ‡ āđāļĨāļ°āļĢāļ°āļĒāļ°āļŠāļļāļ”āļ—āđ‰āļēāļĒ āđ‚āļ”āļĒāļ—āļĩāđˆāļ­āļēāļāļēāļĢāļĄāļąāļāļˆāļ°āđāļĒāđˆāļĨāļ‡āļ•āļēāļĄāđ€āļ§āļĨāļēāđāļĨāļ°āļĢāļ°āļĒāļ°āļ‚āļ­āļ‡āđ‚āļĢāļ„ āļˆāļ­āļ›āļĢāļ°āļŠāļēāļ—āļ•āļēāđ€āļŠāļ·āđˆāļ­āļĄ āđāļšāļšāđāļŦāđ‰āļ‡āļĢāļ°āļĒāļ°āđāļĢāļāļĄāļąāļāļˆāļ°āđ„āļĄāđˆāļĄāļĩāļ­āļēāļāļēāļĢāđƒāļ” āđ† āđƒāļ™ āļˆāļ­āļ›āļĢāļ°āļŠāļēāļ—āļ•āļēāđ€āļŠāļ·āđˆāļ­āļĄ āđāļšāļšāđāļŦāđ‰āļ‡āļĢāļ°āļĒāļ°āļāļĨāļēāļ‡ āļšāļēāļ‡āļ„āļ™āļĒāļąāļ‡āđ„āļĄāđˆāļĄāļĩāļ­āļēāļāļēāļĢ āļšāļēāļ‡āļ„āļ™āļ­āļēāļˆāļŠāļąāļ‡āđ€āļāļ•āđ€āļŦāđ‡āļ™āļ­āļēāļāļēāļĢāđ€āļĨāđ‡āļāļ™āđ‰āļ­āļĒ āđ€āļŠāđˆāļ™ āļ āļēāļžāđ€āļšāļĨāļ­āđ€āļĨāđ‡āļāļ™āđ‰āļ­āļĒāđƒāļ™āļšāļĢāļīāđ€āļ§āļ“āļĻāļđāļ™āļĒāđŒāļāļĨāļēāļ‡āļ āļēāļžāļŦāļĢāļ·āļ­āļ›āļąāļāļŦāļēāđƒāļ™āļāļēāļĢāļĄāļ­āļ‡āđ€āļŦāđ‡āļ™āđƒāļ™āđāļŠāļ‡āļ™āđ‰āļ­āļĒāđƒāļ™ AMD āļĢāļ°āļĒāļ°āļŠāļļāļ”āļ—āđ‰āļēāļĒ (āļ—āļąāđ‰āļ‡āđāļšāļšāđ€āļ›āļĩāļĒāļāđāļĨāļ°āđāļŦāđ‰āļ‡) āļŦāļĨāļēāļĒāļ„āļ™āļŠāļąāļ‡āđ€āļāļ•āđ€āļŦāđ‡āļ™āļ§āđˆāļēāđ€āļŠāđ‰āļ™āļ•āļĢāļ‡āđ€āļĢāļīāđˆāļĄāļ”āļđāđ€āļ›āđ‡āļ™āļ„āļĨāļ·āđˆāļ™āļŦāļĢāļ·āļ­āđ‚āļ„āđ‰āļ‡āļ‡āļ­ āļ„āļļāļ“āļ­āļēāļˆāļŠāļąāļ‡āđ€āļāļ•āđ€āļŦāđ‡āļ™āļšāļĢāļīāđ€āļ§āļ“āļ āļēāļžāđ€āļšāļĨāļ­āđƒāļāļĨāđ‰āļĻāļđāļ™āļĒāđŒāļāļĨāļēāļ‡āļ āļēāļž āđ€āļĄāļ·āđˆāļ­āđ€āļ§āļĨāļēāļœāđˆāļēāļ™āđ„āļ› āļšāļĢāļīāđ€āļ§āļ“āļ āļēāļžāđ€āļšāļĨāļ­āļ™āļĩāđ‰āļ­āļēāļˆāļ‚āļĒāļēāļĒāđƒāļŦāļāđˆāļ‚āļķāđ‰āļ™ āļŠāļĩāļ­āļēāļˆāļ”āļđāđ„āļĄāđˆāļŠāļ”āđƒāļŠāđ€āļŦāļĄāļ·āļ­āļ™āđ€āļ”āļīāļĄ āđāļĨāļ°āļ„āļļāļ“āļ­āļēāļˆāļĄāļĩāļ›āļąāļāļŦāļēāđƒāļ™āļāļēāļĢāļĄāļ­āļ‡āđ€āļŦāđ‡āļ™āđƒāļ™āđāļŠāļ‡āļ™āđ‰āļ­āļĒāļĄāļēāļāļ‚āļķāđ‰āļ™ āļāļēāļĢāļ—āļĩāđˆāđ€āļŠāđ‰āļ™āļ•āļĢāļ‡āļ”āļđāđ€āļ›āđ‡āļ™āļ„āļĨāļ·āđˆāļ™āđ€āļ›āđ‡āļ™āļŠāļąāļāļāļēāļ“āđ€āļ•āļ·āļ­āļ™āļŠāļģāļŦāļĢāļąāļš AMD āļĢāļ°āļĒāļ°āļŠāļļāļ”āļ—āđ‰āļēāļĒ āļŦāļēāļāļ„āļļāļ“āļŠāļąāļ‡āđ€āļāļ•āđ€āļŦāđ‡āļ™āļ­āļēāļāļēāļĢāļ™āļĩāđ‰ āđƒāļŦāđ‰āļžāļšāļˆāļąāļāļĐāļļāđāļžāļ—āļĒāđŒāļ—āļąāļ™āļ—āļĩ āđ€āļĢāļēāļˆāļ°āļĄāļĩāļ§āļīāļ˜āļĩāļāļēāļĢāļĨāļ”āļ„āļ§āļēāļĄāđ€āļŠāļĩāđˆāļĒāļ‡āļ•āđˆāļ­ āđ‚āļĢāļ„āļˆāļ­āļ›āļĢāļ°āļŠāļēāļ—āļ•āļēāđ€āļŠāļ·āđˆāļ­āļĄāļ•āļēāļĄāļ­āļēāļĒāļļ āđ„āļ”āđ‰āļ­āļĒāđˆāļēāļ‡āđ„āļĢ? āļĄāļĩāļŦāļĨāļēāļĒāļ‡āļēāļ™āļ§āļīāļˆāļąāļĒāļ—āļĩāđˆāļšāđˆāļ‡āļšāļ­āļāļ§āđˆāļēāļ–āđ‰āļēāđ€āļĢāļēāļ—āļģāļ•āļēāļĄāļžāļĪāļ•āļīāļāļĢāļĢāļĄāļ•āđˆāļēāļ‡āđ†āđ€āļŦāļĨāđˆāļēāļ™āļĩāđ‰ āļ­āļēāļˆāļŠāļ°āļĨāļ­āļāļēāļĢāđ€āļ›āđ‡āļ™āļˆāļ­āļ›āļĢāļ°āļŠāļēāļ—āļ•āļēāđ€āļŠāļ·āđˆāļ­āļĄ (āļŦāļĢāļ·āļ­āļŠāļ°āļĨāļ­āļāļēāļĢāļŠāļđāļāđ€āļŠāļĩāļĒāļāļēāļĢāļĄāļ­āļ‡āđ€āļŦāđ‡āļ™āļˆāļēāļāļˆāļ­āļ›āļĢāļ°āļŠāļēāļ—āļ•āļēāđ€āļŠāļ·āđˆāļ­āļĄ) āđ„āļ”āđ‰ āđ€āļĨāļīāļāļŠāļđāļšāļšāļļāļŦāļĢāļĩāđˆ āļŦāļĢāļ·āļ­āđ„āļĄāđˆāđ€āļĢāļīāđˆāļĄāļŠāļđāļšāļšāļļāļŦāļĢāļĩāđˆ āļ­āļ­āļāļāļģāļĨāļąāļ‡āļāļēāļĒāļ­āļĒāđˆāļēāļ‡āļŠāļĄāđˆāļģāđ€āļŠāļĄāļ­ āļĢāļąāļāļĐāļēāļĢāļ°āļ”āļąāļšāļ„āļ§āļēāļĄāļ”āļąāļ™āđ‚āļĨāļŦāļīāļ•āđāļĨāļ°āļ„āļ­āđ€āļĨāļŠāđ€āļ•āļ­āļĢāļ­āļĨāđƒāļŦāđ‰āļ›āļāļ•āļī āļāļīāļ™āļ­āļēāļŦāļēāļĢāđ€āļžāļ·āđˆāļ­āļŠāļļāļ‚āļ āļēāļž āļĢāļ§āļĄāļ–āļķāļ‡āļœāļąāļāđƒāļšāđ€āļ‚āļĩāļĒāļ§āđāļĨāļ°āļ›āļĨāļē āļˆāļąāļāļĐāļļāđāļžāļ—āļĒāđŒāļˆāļ°āļ•āļĢāļ§āļˆāļŦāļē AMD āļ­āļĒāđˆāļēāļ‡āđ„āļĢ? āļŠāđˆāļ§āļ™āļĄāļēāļāļˆāļ°āļĄāļĩāđƒāļŠāđ‰āļāļēāļĢāļ•āļĢāļ§āļˆāļ•āļē āđ‚āļ”āļĒāļāļēāļĢāļˆāļ°āļĄāļĩāļāļēāļĢāļ•āļĢāļ§āļˆāļ‚āļĒāļēāļĒāļĄāđˆāļēāļ™āļ•āļē āļ•āļĢāļ§āļˆāļˆāļ­āļ›āļĢāļ°āļŠāļēāļ—āļ•āļē āđāļĨāļ°āļāļēāļĢāļŠāđāļāļ™āļˆāļ­āļ›āļĢāļ°āļŠāļēāļ—āļ•āļēāļ”āđ‰āļ§āļĒāđ€āļ„āļĢāļ·āđˆāļ­āļ‡ Optical Coherence Tomography (OCT)   āļ§āļīāļ˜āļĩāļāļēāļĢāļĢāļąāļāļĐāļēāļˆāļ­āļ›āļĢāļ°āļŠāļēāļ—āļ•āļēāđ€āļŠāļ·āđˆāļ­āļĄ 1. āļāļēāļĢāļĢāļąāļāļĐāļēāļ”āđ‰āļ§āļĒāļĒāļēāđāļĨāļ°āļ­āļēāļŦāļēāļĢāđ€āļŠāļĢāļīāļĄ āļ§āļīāļ•āļēāļĄāļīāļ™āđāļĨāļ°āđāļĢāđˆāļ˜āļēāļ•āļļ: āļāļēāļĢāļĢāļąāļšāļ›āļĢāļ°āļ—āļēāļ™āļ§āļīāļ•āļēāļĄāļīāļ™āļ‹āļĩ, āļ­āļĩ, āđ€āļšāļ•āđ‰āļēāđāļ„āđ‚āļĢāļ—āļĩāļ™, āļŠāļąāļ‡āļāļ°āļŠāļĩ āđāļĨāļ°āļ—āļ­āļ‡āđāļ”āļ‡ āļ­āļēāļˆāļŠāđˆāļ§āļĒāļŠāļ°āļĨāļ­āļāļēāļĢāļĨāļļāļāļĨāļēāļĄāļ‚āļ­āļ‡āļˆāļ­āļ›āļĢāļ°āļŠāļēāļ—āļ•āļēāđ€āļŠāļ·āđˆāļ­āļĄāđāļšāļšāđāļŦāđ‰āļ‡āđƒāļ™āļšāļēāļ‡āļĢāļēāļĒ āļĒāļēāļ‰āļĩāļ”: āļĒāļēāļ•āđ‰āļēāļ™ VEGF (Vascular Endothelial Growth Factor) āđ€āļ›āđ‡āļ™āļāļēāļĢāļĢāļąāļāļĐāļēāļŦāļĨāļąāļāļŠāļģāļŦāļĢāļąāļšāļˆāļ­āļ›āļĢāļ°āļŠāļēāļ—āļ•āļēāđ€āļŠāļ·āđˆāļ­āļĄāđāļšāļšāđ€āļ›āļĩāļĒāļ āļĒāļēāļ™āļĩāđ‰āļŠāđˆāļ§āļĒāļĒāļąāļšāļĒāļąāđ‰āļ‡āļāļēāļĢāļŠāļĢāđ‰āļēāļ‡āđ€āļŠāđ‰āļ™āđ€āļĨāļ·āļ­āļ”āđƒāļŦāļĄāđˆāļ—āļĩāđˆāļœāļīāļ”āļ›āļāļ•āļī 2. āļāļēāļĢāļĢāļąāļāļĐāļēāļ”āđ‰āļ§āļĒāđ€āļĨāđ€āļ‹āļ­āļĢāđŒ Photodynamic therapy (PDT): āđƒāļŠāđ‰āđ€āļĨāđ€āļ‹āļ­āļĢāđŒāļĢāđˆāļ§āļĄāļāļąāļšāļĒāļēāļ‰āļĩāļ”āđ€āļžāļ·āđˆāļ­āļ—āļģāļĨāļēāļĒāđ€āļŠāđ‰āļ™āđ€āļĨāļ·āļ­āļ”āđƒāļŦāļĄāđˆāļ—āļĩāđˆāļœāļīāļ”āļ›āļāļ•āļī Laser photocoagulation: āđƒāļŠāđ‰āđ€āļĨāđ€āļ‹āļ­āļĢāđŒāđ€āļžāļ·āđˆāļ­āļ—āļģāļĨāļēāļĒāđ€āļŠāđ‰āļ™āđ€āļĨāļ·āļ­āļ”āđƒāļŦāļĄāđˆāļ—āļĩāđˆāļœāļīāļ”āļ›āļāļ•āļīāđ‚āļ”āļĒāļ•āļĢāļ‡ 3. āļāļēāļĢāļœāđˆāļēāļ•āļąāļ” āļāļēāļĢāļœāđˆāļēāļ•āļąāļ”āđ€āļ­āļēāđ€āļĨāļ·āļ­āļ”āļ­āļ­āļ: āđƒāļ™āļāļĢāļ“āļĩāļ—āļĩāđˆāđ€āļĨāļ·āļ­āļ”āļ­āļ­āļāđƒāļ™āļ”āļ§āļ‡āļ•āļē āļ­āļēāļˆāļ•āđ‰āļ­āļ‡āļœāđˆāļēāļ•āļąāļ”āđ€āļžāļ·āđˆāļ­āđ€āļ­āļēāđ€āļĨāļ·āļ­āļ”āļ­āļ­āļ āļāļēāļĢāļœāđˆāļēāļ•āļąāļ”āļ›āļĨāļđāļāļ–āđˆāļēāļĒāļˆāļ­āļ›āļĢāļ°āļŠāļēāļ—āļ•āļē: āđ€āļ›āđ‡āļ™āđ€āļ—āļ„āđ‚āļ™āđ‚āļĨāļĒāļĩāđƒāļŦāļĄāđˆāļ—āļĩāđˆāļĒāļąāļ‡āļ­āļĒāļđāđˆāđƒāļ™āļ‚āļąāđ‰āļ™āļ—āļ”āļĨāļ­āļ‡1 āļ‚āđ‰āļ­āļ”āļĩāļ‚āđ‰āļ­āđ€āļŠāļĩāļĒāļ‚āļ­āļ‡āđāļ•āđˆāļĨāļ°āļ§āļīāļ˜āļĩ āļ§āļīāļ˜āļĩāļāļēāļĢāļĢāļąāļāļĐāļē āļ‚āđ‰āļ­āļ”āļĩ āļ‚āđ‰āļ­āđ€āļŠāļĩāļĒ āļ§āļīāļ•āļēāļĄāļīāļ™āđāļĨāļ°āđāļĢāđˆāļ˜āļēāļ•āļļ āļĢāļēāļ„āļēāļ–āļđāļāļ›āļĨāļ­āļ”āļ āļąāļĒ āđ„āļĄāđˆāđ„āļ”āđ‰āļœāļĨāļāļąāļšāļ—āļļāļāļ„āļ™āļ­āļēāļˆāļĄāļĩāļœāļĨāļ‚āđ‰āļēāļ‡āđ€āļ„āļĩāļĒāļ‡āđ€āļĨāđ‡āļāļ™āđ‰āļ­āļĒ āļĒāļēāļ‰āļĩāļ” āđ„āļ”āđ‰āļœāļĨāļ”āļĩāđƒāļ™āļāļēāļĢāļĢāļąāļāļĐāļēāļˆāļ­āļ›āļĢāļ°āļŠāļēāļ—āļ•āļēāđ€āļŠāļ·āđˆāļ­āļĄāđāļšāļšāđ€āļ›āļĩāļĒāļ āļ•āđ‰āļ­āļ‡āļ‰āļĩāļ”āđ€āļ‚āđ‰āļēāļ”āļ§āļ‡āļ•āļēāđ€āļ›āđ‡āļ™āļ›āļĢāļ°āļˆāļģāļ­āļēāļˆāļĄāļĩāļœāļĨāļ‚āđ‰āļēāļ‡āđ€āļ„āļĩāļĒāļ‡ āļāļēāļĢāļĢāļąāļāļĐāļēāļ”āđ‰āļ§āļĒāđ€āļĨāđ€āļ‹āļ­āļĢāđŒ āđ„āļ”āđ‰āļœāļĨāļ”āļĩāđƒāļ™āļāļēāļĢāļ—āļģāļĨāļēāļĒāđ€āļŠāđ‰āļ™āđ€āļĨāļ·āļ­āļ”āđƒāļŦāļĄāđˆ āļ­āļēāļˆāļ—āļģāļĨāļēāļĒāđ€āļ™āļ·āđ‰āļ­āđ€āļĒāļ·āđˆāļ­āļ›āļāļ•āļīāđ‚āļ”āļĒāļĢāļ­āļš, āđ„āļĄāđˆāđ„āļ”āđ‰āļœāļĨāļāļąāļšāļ—āļļāļāļ„āļ™ āļ­āļēāļˆāļŠāđˆāļ§āļĒāļĢāļąāļāļĐāļēāļ āļēāļ§āļ°āđāļ—āļĢāļāļ‹āđ‰āļ­āļ™āļšāļēāļ‡āļ­āļĒāđˆāļēāļ‡ āļĄāļĩāļ„āļ§āļēāļĄāđ€āļŠāļĩāđˆāļĒāļ‡āļˆāļēāļāļāļēāļĢāļœāđˆāļēāļ•āļąāļ”, āđ„āļĄāđˆāđ„āļ”āđ‰āļœāļĨāļāļąāļšāļ—āļļāļāļ„āļ™   āđ€āļ—āļ„āđ‚āļ™āđ‚āļĨāļĒāļĩāđƒāļŦāļĄāđˆāđƒāļ™āļāļēāļĢāļĢāļąāļāļĐāļēāļˆāļ­āļ›āļĢāļ°āļŠāļēāļ—āļ•āļēāđ€āļŠāļ·āđˆāļ­āļĄ āļĒāļēāļ‰āļĩāļ”āļŠāļ™āļīāļ”āđƒāļŦāļĄāđˆ: āļĒāļēāļ‰āļĩāļ”āļ—āļĩāđˆāļ­āļ­āļāļĪāļ—āļ˜āļīāđŒāļ™āļēāļ™āļ‚āļķāđ‰āļ™ āļŠāđˆāļ§āļĒāļĨāļ”āļ„āļ§āļēāļĄāļ–āļĩāđˆāđƒāļ™āļāļēāļĢāļ‰āļĩāļ” Gene therapy: āđ€āļ›āđ‡āļ™āļāļēāļĢāļĢāļąāļāļĐāļēāđ‚āļ”āļĒāļāļēāļĢāđƒāļŠāđˆāļĒāļĩāļ™āļ—āļĩāđˆāļ›āļāļ•āļīāđ€āļ‚āđ‰āļēāđ„āļ›āđƒāļ™āđ€āļ‹āļĨāļĨāđŒāļˆāļ­āļ›āļĢāļ°āļŠāļēāļ—āļ•āļēāđ€āļžāļ·āđˆāļ­āļ‹āđˆāļ­āļĄāđāļ‹āļĄāļ„āļ§āļēāļĄāđ€āļŠāļĩāļĒāļŦāļēāļĒ Stem cell therapy: āđ€āļ›āđ‡āļ™āļāļēāļĢāļĢāļąāļāļĐāļēāđ‚āļ”āļĒāļāļēāļĢāđƒāļŠāđ‰āļŠāđ€āļ•āđ‡āļĄāđ€āļ‹āļĨāļĨāđŒāđ€āļžāļ·āđˆāļ­āļŠāļĢāđ‰āļēāļ‡āđ€āļ‹āļĨāļĨāđŒāļˆāļ­āļ›āļĢāļ°āļŠāļēāļ—āļ•āļēāđƒāļŦāļĄāđˆ   āļŠāļĢāļļāļ›   āļāļēāļĢāļĢāļąāļāļĐāļēāļˆāļ­āļ›āļĢāļ°āļŠāļēāļ—āļ•āļēāđ€āļŠāļ·āđˆāļ­āļĄāļĄāļĩāļŦāļĨāļēāļĒāļ§āļīāļ˜āļĩ āđāļ•āđˆāļĨāļ°āļ§āļīāļ˜āļĩāļĄāļĩāļ‚āđ‰āļ­āļ”āļĩāļ‚āđ‰āļ­āđ€āļŠāļĩāļĒāđāļ•āļāļ•āđˆāļēāļ‡āļāļąāļ™ āļāļēāļĢāđ€āļĨāļ·āļ­āļāļ§āļīāļ˜āļĩāļĢāļąāļāļĐāļēāļ—āļĩāđˆāđ€āļŦāļĄāļēāļ°āļŠāļĄāļ‚āļķāđ‰āļ™āļ­āļĒāļđāđˆāļāļąāļšāļ›āļĢāļ°āđ€āļ āļ—āđāļĨāļ°āļ„āļ§āļēāļĄāļĢāļļāļ™āđāļĢāļ‡āļ‚āļ­āļ‡āđ‚āļĢāļ„ āļĢāļ§āļĄāļ–āļķāļ‡āļŠāļļāļ‚āļ āļēāļžāđ‚āļ”āļĒāļĢāļ§āļĄāļ‚āļ­āļ‡āļœāļđāđ‰āļ›āđˆāļ§āļĒ āļ„āļ§āļĢāļ›āļĢāļķāļāļĐāļēāļˆāļąāļāļĐāļļāđāļžāļ—āļĒāđŒāđ€āļžāļ·āđˆāļ­āļĢāļąāļšāļ„āļģāđāļ™āļ°āļ™āļģāđāļĨāļ°āļāļēāļĢāļĢāļąāļāļĐāļēāļ—āļĩāđˆāđ€āļŦāļĄāļēāļ°āļŠāļĄāļ—āļĩāđˆāļŠāļļāļ”
Retina Center
Understanding Retinal Diseases: A Focus on Age-Related Macular Degeneration (AMD) and How We Can Help
Welcome to our detailed exploration of retinal diseases, specifically focusing on Age-Related Macular Degeneration (AMD), the main cause of vision impairment among older adults. Here at Bangkok Eye Hospital in Thailand, we are dedicated to providing expert care and comprehensive treatment options to manage and potentially mitigate the impact of AMD on your life. Overview of the Retina and Its Function The retina is a critical component of the eye, essential for vision. This thin layer of tissue, located at the back of the eye, captures light and converts it into electrical signals. These signals are sent to the brain, which interprets them as visual images. The retina's functionality is similar to the film in a camera, capturing the world around us and enabling us to see detailed and colorful images.   Understanding Age-Related Macular Degeneration (AMD) Age-Related Macular Degeneration (AMD) is a prevalent retinal condition that primarily affects individuals over the age of 50. It occurs when the central portion of the retina, known as the macula, deteriorates. The macula is responsible for central vision and visual acuity, which is important for tasks such as reading, driving, and recognizing faces.   Types of AMD AMD manifests in two forms: Dry AMD: This is the more common type and is characterized by the thinning of the macula and the presence of drusen, tiny yellow or white deposits on the retina. Dry AMD progresses slowly and gradually impairs central vision. Wet AMD: Less common but more severe, wet AMD occurs when new, abnormal blood vessels grow under the retina, leading to leakage of fluid and blood. This leakage can cause rapid and severe damage to the macula, leading to significant vision loss. Symptoms of AMD The symptoms of AMD can vary but typically include: §  Blurriness in the central part of the vision §  Distorted vision (straight lines appear wavy) §  Difficulty adapting to low light levels §  Decreased intensity or brightness of colors §  A well-defined blurry spot or blind spot in your field of vision   The Impact of AMD on Vision and Lifestyle AMD significantly affects quality of life by impairing the ability to perform everyday activities that require sharp central vision.   “Early detection through regular eye exams is crucial for managing this disease effectively.”   How Bangkok Eye Hospital Can Help At Bangkok Eye Hospital, our approach to managing AMD involves: ü  Early Detection and Regular Monitoring: Utilizing advanced diagnostic tools, we detect AMD in its earliest stages and monitor its progression. ü  Personalized Treatment Plans: Depending on the type and severity of AMD, treatments may include nutritional supplements, laser therapy, and anti-VEGF injections to slow progression and maintain vision. ü  Low Vision Aids and Support: We provide resources and aids to help patients adapt to changes in their vision, ensuring they can continue to enjoy a high quality of life. Conclusion Age-related macular degeneration is a serious condition that can seriously affect your vision. Understanding the symptoms and getting regular eye exams are key to early detection and treatment. If you're experiencing any symptoms of AMD, don't hesitate to contact Bangkok Eye Hospital. Our team of expert ophthalmologists is here to provide you with the highest standard of care and support. For more information or to schedule a consultation, contact us at lasik-eng@laservisionthai.com. Disclaimer: The information provided here is intended for general informational purposes only. Please consult with our specialists for a comprehensive assessment and personalized treatment plan. Your specific condition will require a tailored approach, which can only be accurately determined through a professional evaluation. #AMD #RetinalDiseases #EyeHealth #VisionCare #EarlyDetection #BangkokEyeHospital
Cataract Center
Laser Vision Lasik Center
Understanding Age-Related Eye Health Issues and Care
Understanding Age-Related Eye Health Issues and Care As we age, it's natural to prioritize physical health, working diligently to prevent diseases such as diabetes, heart conditions, and high blood pressure. However, one aspect that often gets less attention is our eye health. Surprisingly, a survey by The International Agency for the Prevention of Blindness (IAPB) revealed that a significant 80% of individuals over the age of 50 experience various eye problems, with some facing the daunting prospect of blindness.   Age-Related Eye Problems   1. Presbyopia: The Age-Related Vision Challenge This age-related vision issue, known as presbyopia, typically emerges in one's early 40s or later. It's akin to looking through a foggy window, causing a decline in sharpness, particularly noticeable when driving at night.   2. Glaucoma: The Silent Thief of Sight Glaucoma, characterized by elevated eye pressure, stiffens the eye, affecting peripheral vision while retaining central vision. There are two main types: closed-angle and open-angle glaucoma. Closed-angle glaucoma is more prevalent in elderly women, causing sudden eye pain and blurred vision, necessitating immediate attention. In contrast, chronic open-angle glaucoma is often asymptomatic, making regular eye exams crucial for early detection.   3. Age-Related Macular Degeneration (AMD): A Leading Cause of Vision Loss Age-Related Macular Degeneration (AMD) is a significant contributor to vision loss in the elderly. It starts with clear peripheral vision but blurry central vision due to macular tissue abnormalities. It often has a hereditary component and is associated with risk factors such as high blood pressure, high cholesterol, obesity, and smoking.   Other Eye Health Concerns   4. Floaters: Understanding Those Pesky Spots Floaters, those small dark spots or streaks in your vision, can resemble flying insects. These result from changes in the vitreous substance inside the eye. While they're usually harmless, an excessive amount, accompanied by decreased vision, should prompt a visit to an ophthalmologist.   5. Cataracts: The Clouding of Vision Cataracts, the clouding of the eye's lens leads to reduced vision. Cataracts are common among the elderly and can be related to aging, diabetes, high blood pressure, and smoking. Surgical removal is often necessary when they significantly impair vision.   Regular Eye Health Check-ups Just like overall physical health, it's vital to schedule regular eye check-ups, at least annually, with a specialist.   Conclusion: Optimizing Eye Health in Your Golden Years In your pursuit of a healthy and fulfilling life as you age, don't overlook the significance of eye health. By understanding common age-related eye issues and the importance of regular check-ups, you can safeguard your vision and enjoy a vibrant, active lifestyle well into your golden years.        
calling
Contact Us : +66 84 979 3594